| mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.0091 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.056 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.9 |